Clinical Trials for Integro Theranostics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Integro Theranostics

Clinical Trials (2)

NCT06713564
A Single Dose, Open-Label, Dose-escalation Study of the Safety and Imaging Characteristics of LS301-IT for Intraoperative Imaging of Lung Cancer
PHASE1Active, not recruiting
24 participants
Started: Nov 7, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05900986
LS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
PHASE1/PHASE2Active, not recruiting
100 participants
Started: Jul 14, 2023 · Completed: May 31, 2026
3 conditions1 sponsor9 locations